About: Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) article scientifique publié en 1998 (fr) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1998 (ast) artikull shkencor i botuar më 01 shkurt 1998 (sq) scientific article published on 01 February 1998 (en)
publication date	wds:Q74343730-31F93488-E5A1-4CC5-A6C7-90BF6259E122
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q74343730-20A734AF-CF6E-450C-8587-83F224082D8B
exact match	https://scigraph.springernature.com/pub.10.1023/a:1018825532059
cites work	wds:Q74343730-0FACD966-8E1B-4340-BF82-30C1CC76D0DB wds:Q74343730-41E435D6-C4FC-46DB-BB98-612338225720 wds:Q74343730-4A3B9650-4F25-4B58-B0F6-115569A25D4B wds:Q74343730-4D94381E-742F-4D26-94ED-31EC154B14EF wds:Q74343730-57323937-6FC2-4EE5-B01D-FD8E082946D2 wds:Q74343730-6E373F9C-EB63-479D-8B86-0A8D41E8F8EE wds:Q74343730-7014BC2B-5955-45B2-93CF-7E36D26EBEFD wds:Q74343730-83F6EF81-3B36-418D-A2B1-27D9E7DC7468 wds:Q74343730-86D07E0B-05FF-4506-8278-9E359C2134CC wds:Q74343730-9121D126-4BA8-4228-BE6D-90A31A76A690 wds:Q74343730-9F40EF83-62F8-4D50-BF4E-60534249C220 wds:Q74343730-B1759556-B1BE-458D-B2F8-BAC55941914F wds:Q74343730-C1D7DC81-932D-4626-849A-FE27E7C50FDC wds:Q74343730-CE6344FA-02CA-44B8-9068-EE78E10E04CC wds:Q74343730-D4347722-04A6-460A-8A32-7A25AF81E461 wds:Q74343730-E0A82504-04D1-4CD0-99C8-D1BA3918961E wds:Q74343730-E23D15E2-8E99-4062-AD99-8F3F3E94E951 wds:Q74343730-EF2F33F3-3B62-4B37-B05B-8A6B6D5D169A
cites work	Immune and inflammatory responses to Helicobacter pylori infection Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa Pathogenic properties of Helicobacter pylori Cytokine gene expression in Helicobacter pylori associated antral gastritis Diethyldithiocarbamate, a superoxide dismutase inhibitor, reduces indomethacin-induced gastric lesions in rats Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils Review of Helicobacter pylori eradication regimens. Pooled analysis of anti-Helicobacter pylori treatment regimens. Eradication of Helicobacter pylori: omeprazole in combination with antibiotics. Prevention of Helicobacter pylori infection.
author name string	wds:Q74343730-03E5FEDC-1F67-42D6-800E-92E091030EA7 wds:Q74343730-0C0BECAB-A7D5-49B0-B6EE-102F7E6F0D21 wds:Q74343730-0FB1B843-4611-4881-9FBB-4776702A2608 wds:Q74343730-55ACDD72-CA73-47B1-8678-60C77AFDD7E7 wds:Q74343730-686EF72A-DD2E-465D-8850-463C8477EF48 wds:Q74343730-8B0B22C0-476A-4727-8899-A0D78D514EEB wds:Q74343730-CBF6F503-22AB-457B-960A-5DE081F857E1
author name string	Y S Kim K J Lee J H Kim S W Cho K B Hahm H Yim H J Joo
rdfs:label	Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (en) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (nl) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (sq)
skos:prefLabel	Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (en) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (nl) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (sq)
name	Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (en) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (nl) Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (sq)
title	wds:Q74343730-7BB4DE70-6E04-4846-A326-DC4D93447A17
title	Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide (en)
page(s)	wds:Q74343730-4D847890-73F5-43DC-8BB4-CF3A6DEE8469
page(s)	235-240
instance of	wds:Q74343730-3E0A223D-CCB7-475F-B255-D9E0AE7C0A1C
instance of	scholarly article
main subject	wds:Q74343730-0344EE6E-7166-4143-8C5C-8435052E0C32 wds:Q74343730-03A51FEF-3165-41C0-B657-022FEC5E85B9 wds:Q74343730-F58D0D48-854C-48AC-8B92-2F83DEA05793
main subject	Helicobacter pylori amoxicillin Helicobacter pylori infectious disease
PubMed ID	wds:Q74343730-D932034F-A8DA-453B-B638-62E1957D03D4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9512112
PubMed ID	9512112
published in	wds:Q74343730-073CAEF0-D523-48E3-9F22-4129207B8F87
published in	Digestive Diseases and Sciences
issue	wds:Q74343730-D7D38574-EE98-4535-9C3B-60197D3D2B64
volume	wds:Q74343730-0CD77F0B-77C2-4202-8C01-A60AD7729CC0
issue	2
volume	43
DOI	wds:Q74343730-F6BE7A45-616B-413F-A074-592D6EF5DFE6
DOI	http://dx.doi.org/10.1023/A:1018825532059
DOI	10.1023/A:1018825532059
Dimensions Publication ID	wds:Q74343730-E7EB84C5-42BA-431E-9597-27A1F8A028D1
Dimensions Publication ID	1022613606
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74343730
is cites work of	Gastritis and gastric cancer. Western countries NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software